Partner Stephanie Sharron will be serving on a panel discussing “Accelerating Drug Development with Impactful Data” at the upcoming CABS BioPacific Conference. Stephanie will join other leaders in the field to explore the transformative potential of artificial intelligence (AI) in drug development, among other cutting-edge topics.